Immupharma plc — RNS

Regulatory news across IMM

Date	Time	Date	TitleTitle (filtered)	Source
05/02/18	07:00:05	5 Feb 2018	Holding(s) in Company	Holding(s) in Company	RNS
31/01/18	10:23:14	31 Jan 2018	Holding(s) in Company	Holding(s) in Company	RNS
24/01/18	07:00:04	24 Jan 2018	Successful Placing to Raise £10 Million	Successful Placing to Raise £10 Million	RNS
18/01/18	07:00:07	18 Jan 2018	Completion of LupuzorT Pivotal Phase III Study	Completion of LupuzorT Pivotal Phase III Study	RNS
21/12/17	07:05:01	21 Dec 2017	Grant of Options	Grant of Options	RNS
21/12/17	07:00:04	21 Dec 2017	Last patient completes dosing in LupuzorT Trial	Last patient completes dosing in LupuzorT Trial	RNS
28/11/17	12:00:27	28 Nov 2017	Holding(s) in Company	Holding(s) in Company	RNS
24/11/17	13:32:03	24 Nov 2017	Grant of Options	Grant of Options	RNS
02/11/17	07:00:04	2 Nov 2017	Update on LupuzorT Pivotal Phase III Study	Update on LupuzorT Pivotal Phase III Study	RNS
16/10/17	16:29:03	16 Oct 2017	Holding(s) in Company	Holding(s) in Company	RNS
04/10/17	08:00:05	4 Oct 2017	Completion of Lanstead Sharing Agreement	Completion of Lanstead Sharing Agreement	RNS
27/09/17	08:00:02	27 Sept 2017	Interim Results	Interim Results	RNS
26/09/17	08:00:03	26 Sept 2017	Preparation of Lupuzor'sT Regulatory Submissions	Preparation of Lupuzor'sT Regulatory Submissions	RNS
21/09/17	08:00:03	21 Sept 2017	Update on LupuzorT Pivotal Phase III Study	Update on LupuzorT Pivotal Phase III Study	RNS
19/09/17	08:00:08	19 Sept 2017	Notification of Interim Results	Notification of Interim Results	RNS
18/08/17	18:09:20	18 Aug 2017	AIM Rule 17 Notice	AIM Rule 17 Notice	RNS
12/07/17	12:00:02	12 Jul 2017	Grant of Options	Grant of Options	RNS
30/06/17	13:04:58	30 Jun 2017	Result of AGM	Result of AGM	RNS
30/06/17	08:00:02	30 Jun 2017	Update on LupuzorT Pivotal Phase III Study	Update on LupuzorT Pivotal Phase III Study	RNS
07/06/17	08:00:05	7 Jun 2017	Annual Report & Notice of AGM	Annual Report & Notice of AGM	RNS
01/06/17	08:00:03	1 Jun 2017	Final Results	Final Results	RNS
22/05/17	08:00:11	22 May 2017	Notification of Full Year Results	Notification of Full Year Results	RNS
17/05/17	08:00:08	17 May 2017	Update on Lupuzor Phase III Study	Update on Lupuzor Phase III Study	RNS
31/03/17	11:17:52	31 Mar 2017	New Employee Share Option Plan & Grant of Options	New Employee Share Option Plan & Grant of Options	RNS
31/03/17	09:33:06	31 Mar 2017	New Employee Share Option Plan & Grant of Options	New Employee Share Option Plan & Grant of Options	RNS
24/03/17	07:00:09	24 Mar 2017	ImmuPharma to present at Master Investor Show	ImmuPharma to present at Master Investor Show	RNS
22/03/17	08:51:45	22 Mar 2017	Holding(s) in Company	Holding(s) in Company	RNS
20/03/17	11:41:45	20 Mar 2017	Holding(s) in Company	Holding(s) in Company	RNS
20/03/17	07:00:10	20 Mar 2017	Holding(s) in Company	Holding(s) in Company	RNS
10/03/17	15:52:12	10 Mar 2017	£4.1 Million Fund Raise via Accelerated Bookbuild	£4.1 Million Fund Raise via Accelerated Bookbuild	RNS
10/03/17	07:00:08	10 Mar 2017	Accelerated Bookbuild for the Issue of Equity	Accelerated Bookbuild for the Issue of Equity	RNS
06/03/17	15:55:36	6 Mar 2017	Holding(s) in Company	Holding(s) in Company	RNS
17/02/17	14:04:05	17 Feb 2017	Holding(s) in Company	Holding(s) in Company	RNS
29/12/16	10:54:57	29 Dec 2016	Holding(s) in Company	Holding(s) in Company	RNS
22/12/16	07:00:07	22 Dec 2016	Update on Lupuzor Pivotal Phase III Study	Update on Lupuzor Pivotal Phase III Study	RNS
09/11/16	07:00:11	9 Nov 2016	Holding(s) in Company	Holding(s) in Company	RNS
26/10/16	16:42:12	26 Oct 2016	Holding(s) in Company	Holding(s) in Company	RNS
21/10/16	18:13:43	21 Oct 2016	Close of Accelerated Bookbuild	Close of Accelerated Bookbuild	RNS
21/10/16	14:33:05	21 Oct 2016	Proposed Accelerated Bookbuild for Vendor Placing	Proposed Accelerated Bookbuild for Vendor Placing	RNS
30/09/16	08:00:07	30 Sept 2016	Half-year Report	Half-year Report	RNS
14/09/16	08:00:09	14 Sept 2016	UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY	UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY	RNS
07/09/16	08:00:07	7 Sept 2016	UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY	UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY	RNS
21/07/16	09:32:38	21 Jul 2016	Holding(s) in Company	Holding(s) in Company	RNS
01/07/16	16:52:59	1 Jul 2016	Holding(s) in Company	Holding(s) in Company	RNS
27/06/16	17:41:05	27 Jun 2016	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
27/06/16	17:35:52	27 Jun 2016	Price Monitoring Extension	Price Monitoring Extension	RNS
20/06/16	08:00:08	20 Jun 2016	Appointment of Joint Broker	Appointment of Joint Broker	RNS
09/06/16	18:56:48	9 Jun 2016	Holding(s) in Company	Holding(s) in Company	RNS
08/06/16	08:00:07	8 Jun 2016	Symposium with Lupuzors Inventor Prof. S Muller	Symposium with Lupuzors Inventor Prof. S Muller	RNS
07/06/16	08:00:08	7 Jun 2016	European Patients Commence Dosing in Lupuzor	European Patients Commence Dosing in Lupuzor	RNS

Showing 301–350 of 409 announcements